# Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring

> **NCT01515371** · PHASE2 · TERMINATED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 8 (actual)

## Conditions studied

- Habitual Snoring

## Interventions

- **DRUG:** IncobotulinumtoxinA
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01515371
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-11
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Due to lack of sufficient eligible subjects, no safety concerns
- **Last updated:** 2013-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515371, "Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01515371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*